Published in Transplantation on June 15, 2002
Protective effect of milk fat globule-epidermal growth factor-factor VIII after renal ischemia-reperfusion injury in mice. Crit Care Med (2011) 1.58
Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab Invest (2008) 1.22
Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury. Am J Physiol Renal Physiol (2008) 1.14
Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One (2008) 1.08
ATF3-mediated epigenetic regulation protects against acute kidney injury. J Am Soc Nephrol (2010) 1.01
Human heat shock protein 27 overexpressing mice are protected against hepatic ischemia and reperfusion injury. Transplantation (2009) 1.00
Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am J Pathol (2003) 0.98
Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury. J Am Soc Nephrol (2008) 0.96
Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol (2010) 0.93
Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J Immunol (2012) 0.91
Disruption of guanylyl cyclase-G protects against acute renal injury. J Am Soc Nephrol (2008) 0.88
Numb protects renal proximal tubular cells from puromycin aminonucleoside-induced apoptosis through inhibiting Notch signaling pathway. Int J Biol Sci (2011) 0.85
Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol (2003) 0.83
A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2012) 0.81
Protective effect of epigallocatechin gallate, a major constituent of green tea, against renal ischemia-reperfusion injury in rats. Int Urol Nephrol (2015) 0.81
Protective effects of HBSP on ischemia reperfusion and cyclosporine a induced renal injury. Clin Dev Immunol (2013) 0.81
Exogenous adenosine enhances caspase-3 activity in warm renal ischaemia. Pflugers Arch (2003) 0.79
Stimulation of carnitine palmitoyltransferase 1 improves renal function and attenuates tissue damage after ischemia/reperfusion. J Surg Res (2012) 0.79
Glycyrrhizin protects mice against renal ischemia-reperfusion injury through inhibition of apoptosis and inflammation by downregulating p38 mitogen-activated protein kinase signaling. Exp Ther Med (2014) 0.79
Intestinal fatty acid-binding protein and gut permeability responses to exercise. Eur J Appl Physiol (2017) 0.78
Probing the immune and healing response of murine intestinal mucosa by time-lapse 2-photon microscopy of laser-induced lesions with real-time dosimetry. Biomed Opt Express (2014) 0.77
AS-IV protects against kidney IRI through inhibition of NF-κB activity and PUMA upregulation. Int J Clin Exp Med (2015) 0.77
Protective role of silymarin in a mouse model of renal Ischemia-Reperfusion injury. Diagn Pathol (2015) 0.77
Autophagy activation attenuates renal ischemia-reperfusion injury in rats. Exp Biol Med (Maywood) (2015) 0.77
Exogenous acid fibroblast growth factor inhibits ischemia-reperfusion-induced damage in intestinal epithelium via regulating P53 and P21WAF-1 expression. World J Gastroenterol (2005) 0.77
Tolerance-inducing strategies in transplantation surgery-current status and perspectives. Langenbecks Arch Surg (2003) 0.77
Association of pre-transplant statin use with delayed graft function in kidney transplant recipients. BMC Nephrol (2012) 0.76
Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile. BMC Nephrol (2016) 0.76
Apoptotic cell administration is detrimental in murine renal ischaemia reperfusion injury. J Inflamm (Lond) (2014) 0.75
Gypenoside attenuates renal ischemia/reperfusion injury in mice by inhibition of ERK signaling. Exp Ther Med (2016) 0.75
Ischaemic/reperfusion injury: Role of infliximab. World J Transplant (2012) 0.75
Evaluation of potential changes in liver and lung tissue of rats in an ischemia-reperfusion injury model (modified pringle maneuver). PLoS One (2017) 0.75
Spermidine is protective against kidney ischemia and reperfusion injury through inhibiting DNA nitration and PARP1 activation. Anat Cell Biol (2017) 0.75
Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet (2011) 3.65
Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis (2008) 2.89
In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol (2002) 2.76
Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab (2010) 2.33
Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med (2002) 2.32
Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet (2012) 2.29
Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest (2014) 2.27
Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath. J Hepatol (2012) 1.87
Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med (2005) 1.81
Kidneys from donors after cardiac death provide survival benefit. J Am Soc Nephrol (2010) 1.76
Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol (2003) 1.71
Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol (2002) 1.71
Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity (Silver Spring) (2009) 1.70
Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol (2005) 1.65
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. J Immunol (2006) 1.59
Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit Care Med (2005) 1.58
Hyperglycemia in children with meningococcal sepsis and septic shock: the relation between plasma levels of insulin and inflammatory mediators. J Clin Endocrinol Metab (2006) 1.57
Cholecystokinin/Cholecystokinin-1 receptor-mediated peripheral activation of the afferent vagus by enteral nutrients attenuates inflammation in rats. Ann Surg (2010) 1.51
Gut mucosal cell damage in meningococcal sepsis in children: relation with clinical outcome. Crit Care Med (2010) 1.49
Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg (2010) 1.49
Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int (2010) 1.48
Aspiration pneumonitis primes the host for an exaggerated inflammatory response during pneumonia. Crit Care Med (2005) 1.46
Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis. J Hepatol (2011) 1.46
Early insulin sensitivity after restrictive bariatric surgery, inconsistency between HOMA-IR and steady-state plasma glucose levels. Surg Obes Relat Dis (2009) 1.43
Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol (2009) 1.41
Prevention of hemolysis-induced organ damage by nutritional activation of the vagal anti-inflammatory reflex*. Crit Care Med (2013) 1.40
Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes. Obes Surg (2014) 1.40
Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring) (2013) 1.31
The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol (2004) 1.28
Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation (2003) 1.27
Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol (2007) 1.27
Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol (2003) 1.26
Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. Am J Pathol (2007) 1.24
Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg (2011) 1.22
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health. Nat Commun (2013) 1.20
Cardiovascular surgery and organ damage: time to reconsider the role of hemolysis. J Thorac Cardiovasc Surg (2011) 1.20
Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection. World J Surg (2007) 1.20
A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol (2009) 1.18
Endotoxin induced chorioamnionitis prevents intestinal development during gestation in fetal sheep. PLoS One (2009) 1.17
Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model. Am J Pathol (2010) 1.16
Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology (2009) 1.16
Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring) (2009) 1.16
Non-invasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg (2010) 1.16
Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study. Crit Care (2012) 1.16
Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock (2007) 1.15
Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clin Nutr (2009) 1.14
Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor-alpha and preserves gut barrier function early after hemorrhagic shock. Shock (2004) 1.13
Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study. Ann Surg (2012) 1.13
Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology (2012) 1.13
Localization of the lipopolysaccharide recognition complex in the human healthy and inflamed premature and adult gut. Inflamm Bowel Dis (2010) 1.11
Challenges in diagnosing mesenteric ischemia. World J Gastroenterol (2013) 1.11
Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun (2005) 1.10
Kidney transplantation from donors after cardiac death: a 25-year experience. Transplantation (2010) 1.10
Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS One (2011) 1.10
Genetic and epigenetic regulation of gene expression in fetal and adult human livers. BMC Genomics (2014) 1.09
Evaluation of the diagnostic accuracy of plasma markers for early diagnosis in patients suspected for acute appendicitis. Acad Emerg Med (2013) 1.08
Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One (2008) 1.08
Lipid-rich enteral nutrition reduces postoperative ileus in rats via activation of cholecystokinin-receptors. Ann Surg (2009) 1.08
Intestinal-FABP and liver-FABP: Novel markers for severe abdominal injury. Acad Emerg Med (2010) 1.07
Level of activation of the unfolded protein response correlates with Paneth cell apoptosis in human small intestine exposed to ischemia/reperfusion. Gastroenterology (2010) 1.07
Intestinal cytoskeleton degradation precedes tight junction loss following hemorrhagic shock. Shock (2009) 1.07
Citrulline a more suitable substrate than arginine to restore NO production and the microcirculation during endotoxemia. PLoS One (2012) 1.06
Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg (2012) 1.06
Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation (2004) 1.05
Intestinal permeability and carrier-mediated monosaccharide absorption in preterm neonates during the early postnatal period. Pediatr Res (2002) 1.05
Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg (2013) 1.05
C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice. Circulation (2007) 1.04
Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia. PLoS One (2012) 1.03
Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation (2009) 1.03
Enterocyte shedding and epithelial lining repair following ischemia of the human small intestine attenuate inflammation. PLoS One (2009) 1.02
Urine-based detection of intestinal tight junction loss. J Clin Gastroenterol (2010) 1.01
Early stress protein gene expression in a human model of ischemic preconditioning. Transplantation (2004) 1.00
Physiology and pathophysiology of splanchnic hypoperfusion and intestinal injury during exercise: strategies for evaluation and prevention. Am J Physiol Gastrointest Liver Physiol (2012) 1.00
Visceral injury and systemic inflammation in patients undergoing extracorporeal circulation during aortic surgery. Ann Surg (2008) 1.00
New Insight in Loss of Gut Barrier during Major Non-Abdominal Surgery. PLoS One (2008) 1.00
Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab (2002) 0.99
Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study. BMC Med Genomics (2010) 0.98
Enteral administration of high-fat nutrition before and directly after hemorrhagic shock reduces endotoxemia and bacterial translocation. Ann Surg (2004) 0.97
Rapid development of intestinal cell damage following severe trauma: a prospective observational cohort study. Crit Care (2009) 0.96
The significance of bowel permeability. Curr Opin Clin Nutr Metab Care (2007) 0.96
Butyrate enemas improve intestinal anastomotic strength in a rat model. Dis Colon Rectum (2010) 0.96
Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study. Obes Surg (2004) 0.96
Preadipocyte number in omental and subcutaneous adipose tissue of obese individuals. Obes Res (2004) 0.96
Additional value of serum I-FABP levels for evaluating celiac disease activity in children. Scand J Gastroenterol (2011) 0.94
Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. PLoS One (2012) 0.93
Reduced Paneth cell antimicrobial protein levels correlate with activation of the unfolded protein response in the gut of obese individuals. J Pathol (2011) 0.93
High-fat enteral nutrition reduces endotoxin, tumor necrosis factor-alpha and gut permeability in bile duct-ligated rats subjected to hemorrhagic shock. J Hepatol (2004) 0.92
Small intestinal alterations in severely obese hyperglycemic subjects. J Clin Endocrinol Metab (2010) 0.92
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer. Breast Cancer Res (2013) 0.92
Acute ischemic injury to the renal microvasculature in human kidney transplantation. Am J Physiol Renal Physiol (2010) 0.92
Biological modulation of renal ischemia-reperfusion injury. Curr Opin Organ Transplant (2010) 0.91
Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model. J Clin Gastroenterol (2014) 0.91
Non-invasive markers of gut wall integrity in health and disease. World J Gastroenterol (2010) 0.90
Rapid pulmonary expression of acute-phase reactants after local lipopolysaccharide exposure in mice is followed by an interleukin-6 mediated systemic acute-phase response. Exp Lung Res (2006) 0.90
In situ preservation of kidneys from donors after cardiac death: results and complications. Ann Surg (2007) 0.90